These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 6732436)
1. Fluphenazine and tardive dyskinesia. Perényi A; Arató M Arch Gen Psychiatry; 1984 Jul; 41(7):727. PubMed ID: 6732436 [No Abstract] [Full Text] [Related]
2. The use of fluphenazines in a continuing-care program. Owens D Hosp Community Psychiatry; 1978 Feb; 29(2):115-8. PubMed ID: 620998 [TBL] [Abstract][Full Text] [Related]
7. Tardive dyskinesia and current dose of neuroleptic drugs. Kolakowska T; Williams AO; Ardern M Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034 [No Abstract] [Full Text] [Related]
8. A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients. Inderbitzin LB; Lewine RR; Scheller-Gilkey G; Swofford CD; Egan GJ; Gloersen BA; Vidanagama BP; Waternaux C Am J Psychiatry; 1994 Dec; 151(12):1753-9. PubMed ID: 7977881 [TBL] [Abstract][Full Text] [Related]
9. Fluphenazine decanoate and tardive dyskinesia: a possible association. Csernansky JG; Grabowski K; Cervantes J; Kaplan J; Yesavage JA Am J Psychiatry; 1981 Oct; 138(10):1362-5. PubMed ID: 7294195 [TBL] [Abstract][Full Text] [Related]
10. The effects of a drug holiday on relapse and tardive dyskinesia in chronic schizophrenics [proceedings]. Goldberg SC; Shenoy RS; Sadler A; Hamer R; Ross B Psychopharmacol Bull; 1981 Jan; 17(1):116-7. PubMed ID: 7232638 [No Abstract] [Full Text] [Related]
11. Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response. Marder SR; Midha KK; Van Putten T; Aravagiri M; Hawes EM; Hubbard JW; McKay G; Mintz J Br J Psychiatry; 1991 May; 158():658-65. PubMed ID: 1860020 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study. Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445 [No Abstract] [Full Text] [Related]
15. Follow-up study of 281 schizophrenic patients treated with high dosage fluphenazine decanoate. Steiner S; Nagy C Int Pharmacopsychiatry; 1981; 16(3):184-92. PubMed ID: 7319750 [TBL] [Abstract][Full Text] [Related]
16. Low-dose neuroleptic treatment of outpatient schizophrenics. I. Preliminary results for relapse rates. Kane JM; Rifkin A; Woerner M; Reardon G; Sarantakos S; Schiebel D; Ramos-Lorenzi J Arch Gen Psychiatry; 1983 Aug; 40(8):893-6. PubMed ID: 6347119 [TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia in outpatients on depot phenothiazine. Neehall J West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics]. Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874 [No Abstract] [Full Text] [Related]